Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
243.98
+0.51 (0.21%)
Jun 27, 2025, 4:00 PM - Market closed
Bio-Rad Laboratories Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$324.25
Upside
+32.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $260 → $245 | Hold | Maintains | $260 → $245 | +0.42% | Jun 9, 2025 |
| UBS | UBS | Strong Buy Maintains $355 → $310 | Strong Buy | Maintains | $355 → $310 | +27.06% | May 2, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $400 → $350 | Strong Buy | Maintains | $400 → $350 | +43.45% | May 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $409 → $392 | Buy | Maintains | $409 → $392 | +60.67% | May 2, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $320 → $270 | Hold | Maintains | $320 → $270 | +10.66% | Apr 17, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $360 → $345 | Hold | Maintains | $360 → $345 | +41.41% | Feb 12, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $481 | Buy | Reiterates | $481 | +97.15% | Jan 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $369 → $481 | Buy | Maintains | $369 → $481 | +97.15% | Dec 9, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $400 → $450 | Strong Buy | Maintains | $400 → $450 | +84.44% | Oct 31, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $446 → $469 | Buy | Maintains | $446 → $469 | +92.23% | Oct 31, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $350 → $400 | Hold → Strong Buy | Upgrades | $350 → $400 | +63.95% | Oct 1, 2024 |
| Wells Fargo | Wells Fargo | Hold Initiates $340 | Hold | Initiates | $340 | +39.36% | Aug 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $401 | Buy | Reiterates | $401 | +64.36% | Aug 16, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $402 → $401 | Buy | Maintains | $402 → $401 | +64.36% | Aug 2, 2024 |
| Citigroup | Citigroup | Hold Maintains $300 → $350 | Hold | Maintains | $300 → $350 | +43.45% | Aug 2, 2024 |
| UBS | UBS | Strong Buy Maintains $420 → $385 | Strong Buy | Maintains | $420 → $385 | +57.80% | May 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.